Founded in 1961, the PPMA is recognized by the government of Pakistan as the only representative Pharma body in the country which has about 400 members which comprises both national and multinational companies. Pakistan Pharma Industry is very vibrant and dynamic comprising more than 700 units, currently fulfilling more than 95% of the domestic Pharmaceutical requirements. One of the goals is to ensure availability of quality medicines to all at reasonable price and to enhance exports of the country by accessing more value added markets of Europe and USA.

• Alignment with Global Landscape - A Futuristic Approach
• New Emerging Therapeutics and Regulatory Imperatives
• CEO Panel: Reshaping Pakistan‘s Pharmaceutical Industry: Challenges & Opportunities
• Creating Health Awareness: Role of Pharmaceutical Industry of Pakistan
• Phytopharmaceuticals – Innovation | Quality | Regulatory
• Igniting Digital Pharma
• Regulatory Guidelines – Present and future scenario
• Pharmaceutical Serialization – track and trace system

The crossroads that Pharma industry finds itself at can be summed up in the opening lines of the Charles Dicken‘s novel, A Tale OF Two Cities, "It was the best of times, it was the worst of times".

The Future looks promising yet laced with perils. As human intellect dynamically evolves & knowledge of things improve by leaps and bounds our scientific base is also expanding proportionally. Lengthening human life expectancy has increased the demand for medicines (global Pharma market expected to reach $ 1.12 Trillion by 2022) & advances in genetic& genomics has tectonically shifted the balance. Technology has taken the game to the next level.

New emerging therapeutics create a sweet spot where biology & technology converge to open new opportunities. From precision medicine that provides the biological basis of disease to mHealth sensors targeting Parkinson‘s disease, diabetes, cardiovascular disease, asthma and breast cancer to Spritam ,first 3-D FDA approved printed drug for epilepsy, the quantum leap is unbelievable.

3rd Pharma summit draws exceptional brains in a quest to write answers to these challenging questions that life throws at us at lightning speed. The event also provides one of the rare opportunities to deepen our insight & expand our knowledge to ensure a brighter future. The Summit also features panel discussions & success stories for a profound learning experience. We look forward to your gracious presence to make it an unforgettable experience of your life.

• Most Interesting Man Revolutionizing The Health World‘s Forbes 2014
• Biosimilars Pioneer, Inventor, Teacher and Author
• Founder, Therapeutic Proteins, a Biosimilars Company, USA
• Adjunct Professor, University of Illinois, Chicago
• Sitara-e-Imtiaz

• Board Member of Finzelberg (Business unit of Martin Bauer Group)
• Director, European Technical Services, Amway
• Ex-European Director Regulatory Affairs, Quality Assurance & Product
• Development Liaison, Access Business Group